Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Haisco, Innovent, Iovance, Lupeng, Lupin, Nxera, Quoin, Reach Surgical, Santhera, Shionogi, Wockhardt.